FIELD: veterinary medicine.
SUBSTANCE: preparation for external and local application is applied pointwise or by watering. Pets are cats or dogs. The composition contains an effective amount of 4-[5-(3,5-dichlorophenyl)-5-trifluoromethyl-4,5-dihydroisoxazol-3-yl]-2-methyl-N-[(2,2,2-trifluoroethylcarbamoyl)methyl]benzamide of compound (A) in a veterinarily acceptable liquid carrier. The liquid carrier contains N,N-diethyl-3-methylbenzamide in a mixture of at least two of the following solvents: acetone, ethyl-L-lactate, dimethylsulfoxide, dimethylacetamide and glycofurol, as well as an effective amount of macrocyclic lactone compound and/or insect growth-regulating compound.
EFFECT: good drug penetration in topical application and preservation of an acceptable cosmetic look of the animal.
9 cl, 4 tbl, 7 dwg, 8 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION OF ISOXAZOLINE FOR TOPICAL AND EXTERNAL USE | 2011 |
|
RU2749733C2 |
TOPICAL LOCALIZED ISOXAZOLINE FORMULATION COMPRISING GLYCOFUROL | 2011 |
|
RU2602189C2 |
INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE | 2018 |
|
RU2799591C2 |
SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON ISOXAZOLINE COMPOUNDS | 2013 |
|
RU2646483C2 |
SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON ISOOXAZOLINE COMPOUNDS | 2013 |
|
RU2772279C2 |
SOFT CHEWING PHARMACEUTICAL PRODUCTS | 2013 |
|
RU2632965C2 |
SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | 2013 |
|
RU2765231C2 |
ANTIPARASITIC COMPOSITIONS TO BE USED BY POURING | 2018 |
|
RU2802299C2 |
USE OF ISOXAZOLINE COMPOUNDS FOR DEMODECOSIS TREATMENT | 2015 |
|
RU2709198C2 |
ISOXAZOLINE COMPOSITIONS AND THEIR USE IN THE PREVENTION OR TREATMENT OF PARASITIC INFESTATIONS OF ANIMALS | 2014 |
|
RU2791637C2 |
Authors
Dates
2017-10-11—Published
2011-12-22—Filed